RE: Expectations14 Jul 2023 14:45
For me and I’m not a Trader, this isn’t all about what might or might not happen in 2024, or beyond. We’re going to get some news / updates before then, I hope!
Q3 / Q4 this year could well be interesting and this weeks business update signposts this:
“ Scancell has developed a novel technology platform for producing monoclonal antibodies that recognise glycans with high specificity and affinity. The platform has generated revenues and the antibodies continue to yield compelling results which have led to a new 6-month evaluation by a leading Biotech company. Additional in-house data has illustrated the potential of our antibodies as chimeric antigen receptor T cell (CART) therapies providing the data for a deal with a cell therapy company. These results along with updates on SCIB1 and Modi-1 will be presented at the AACR-CIMT meeting in Milan in September 2023.”
It’s why I’m holding on to my investment at the current time and not pressing the big red panic button.